Company: SVREW
Filing Date: 2025-07-01
Form Type: F-1
Source: 0001213900-25-060400
Chunk: 15

Company: SaverOne 2014 Ltd.
Filing Date: 2025-07-01
Form: F-1
Chunk 15
---

in 10 equal monthly installments beginning on the 90th day from the date of the issuance. On March 19, 2025, Yorkville agreed to modify
the November 24 Promissory Note to postpone the remaining nine monthly payment thereunder by 30 days from the original payment schedule
such that the maturity date was extended to December 11, 2025. The outstanding amounts under the November 24 Promissory Note are repayable
in ADSs issued under the SEPA. As of the date of this prospectus the unpaid outstanding amount on the November 24 Promissory Note is $500,000.

On January 30, 2025, the Company
entered into securities purchase agreements with several institutional investors (the “Purchase Agreements”), pursuant to
which, at the closing (the “Closing”), the Company sold to these investors an aggregate of 195,428,970 Ordinary Shares, represented
by 54,300 ADSs, at an offering price of $27.993 per ADS. The ADSs were sold in a registered direct offering, pursuant to a prospectus
supplement dated January 30, 2025, in connection with a takedown from the Company’s shelf registration statement on Form F-3 (File
No. 333-274458), which became effective by the SEC on September 27, 2023, and the base prospectus dated as of September 27, 2023 contained
in such registration statement. In addition, the Company offered and sold to these investors in a concurrent private placement offering
(the “Private Placement Offering”) unregistered warrants (the “Investor Warrants”) to purchase up to an aggregate
of 108,599 ADSs at an exercise price of $31.992 per ADS, exercisable through February 17, 2027. The Company engaged H.C. Wainwright &
Co., LLC as its exclusive placement agent for the registered and concurrent private placement offering (the “Placement Agent”).
The aggregate proceeds to the Company from this offering were approximately $1,500,000, before deducting the placement agent fees and
other offering expenses payable by the Company.

In addition, at the Closing,
the Company issued warrants to purchase up to an aggregate of 3,801 ADSs, at an exercise price of $34.99125 per share to designees of
the Placement Agent (the “Placement Agent Warrants”). The Placement Agent Warrants have the same terms as the Private